Lithium vs carbamazepine
Lithium showed no clear difference in adverse event: sedation compared with carbamazepine (low certainty).
- OR 0.16 [0.01, 3.64]1 study · 27 participantsLow
Lithium showed no clear difference in adverse event: sedation compared with carbamazepine (low certainty).
Lithium showed no clear difference in adverse events: somnolence/sedation compared with aripiprazole (moderate certainty).
It is very uncertain whether valproate changes adverse events ‐ Sedation At 8 weeks (secondary tolerability outcome) compared with risperidone (very low certainty).
Valproate leads to lower adverse events ‐ Sedation At 3‐12 weeks (secondary tolerability… compared with olanzapine (high certainty).
Valproate showed no clear difference in individual adverse events ‐ Sedation At 3 weeks (secondary… compared with lithium (low certainty).
It is very uncertain whether valproate changes individual adverse events ‐ Sedation At 8 weeks (secondary… compared with lithium (very low certainty).
It is very uncertain whether valproate changes individual adverse events ‐ Sedation At 4 weeks (secondary… compared with placebo (very low certainty).
Valproate showed no clear difference in individual adverse events ‐ Sedation At 3‐8 weeks (secondary… compared with placebo (high certainty).